Medtronic plc (MDT) has a MoatMap StockRank of 77/100 based on Quality (60/100), Value (49/100), and Momentum (48/100) factor scores. The current signal is BUY. Medtronic, a global medical device leader, while a generally high-quality business, does not present an unpriced macro inflection point or asymmetric opportunity linked to the fund's specific themes for the next 18 months, despite its durable moat characteristics.